Accudynamics Acquired by Halma
News Mar 07, 2011
Accudynamics, Inc., a precision manufacturer of components for medical and diagnostic equipment, has been acquired by UK-based Halma p.l.c., a leading safety, health and sensor technology group. Accudynamics will become part of Halma’s global group of fluid technology businesses.
Accudynamics has over 25 years' experience developing and manufacturing instrument components in its production facility. Its precision machined components, integrated electromechanical assemblies, and subassemblies are used by medical and diagnostic equipment manufacturers across the United States, Europe and Japan.
“Accudynamics will become the capstone company for the fluid technology group, offering complete assemblies that incorporate components made by our other companies,” explains Halma’s Fluid Technology Divisional Chief Executive, Chuck Dubois. “I expect extensive collaboration in both approaches to customers as well as new product development.”
Halma’s 36 worldwide subsidiaries focus on industrial safety, health and analysis and infrastructure sensors. Halma typically acquires companies in familiar markets or closely allied sectors. Accudynamics will fit into the fluid technology sector of Halma’s health and analysis business group.
The companies in this group, Alicat Scientific, Bio-Chem Fluidics, Diba Industries and Perma Pure manufacture critical components used by scientific, environmental and medical diagnostic instrument manufacturers for demanding fluid handling applications. Accudynamics already works closely with Diba, incorporating many of Diba’s components into its assemblies.
Commenting on the acquisition, Accudynamics founder and President George Ballou said, “Our successful track record, coupled with the resources of Halma p.l.c., will be a winning combination for the future growth of Accudynamics. Halma brings substantial human and financial resources to the table, while offering the ability to provide customers not only Accudynamics products, but a wide range of fluid technology solutions.”
Researchers at the University of Arizona have completed the first-of-its-kind study that could aid in the treatment, diagnosis and prevention of cervical cancer by identifying cervicovaginal metabolic signatures, or "fingerprints" that distinguish patients with HPV, pre-cancerous cervical conditions and cancer.READ MORE